These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 8425606)

  • 1. Effect of platelet activating factor on the kinetics of LDL oxidation in vitro.
    Deigner HP; Dresel HA
    FEBS Lett; 1993 Feb; 317(3):202-6. PubMed ID: 8425606
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Platelet-activating factor acetylhydrolase and transacetylase activities in human plasma low-density lipoprotein.
    Tsoukatos DC; Liapikos TA; Tselepis AD; Chapman MJ; Ninio E
    Biochem J; 2001 Jul; 357(Pt 2):457-64. PubMed ID: 11439095
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular and mechanistic characterization of platelet-activating factor-like bioactivity produced upon LDL oxidation.
    Androulakis N; Durand H; Ninio E; Tsoukatos DC
    J Lipid Res; 2005 Sep; 46(9):1923-32. PubMed ID: 15995176
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oxidatively fragmented phosphatidylcholines activate human neutrophils through the receptor for platelet-activating factor.
    Smiley PL; Stremler KE; Prescott SM; Zimmerman GA; McIntyre TM
    J Biol Chem; 1991 Jun; 266(17):11104-10. PubMed ID: 1645725
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 1 Acyl-2 acetyl-sn-glycero-3 phosphocholine decreases the susceptibility of low-density lipoprotein to oxidative modification by copper ions, monocytes or endothelial cells.
    Maziere C; Djavahery-Mergny M; Auclair M; Maziere JC
    Biochim Biophys Acta; 1994 Jan; 1210(2):233-8. PubMed ID: 8280775
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inflammatory platelet-activating factor-like phospholipids in oxidized low density lipoproteins are fragmented alkyl phosphatidylcholines.
    Marathe GK; Davies SS; Harrison KA; Silva AR; Murphy RC; Castro-Faria-Neto H; Prescott SM; Zimmerman GA; McIntyre TM
    J Biol Chem; 1999 Oct; 274(40):28395-404. PubMed ID: 10497200
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Platelet-activating factor formation during oxidative modification of low-density lipoprotein when PAF-acetylhydrolase has been inactivated.
    Liapikos TA; Antonopoulou S; Karabina SP; Tsoukatos DC; Demopoulos CA; Tselepis AD
    Biochim Biophys Acta; 1994 Jun; 1212(3):353-60. PubMed ID: 8199206
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipid peroxidation in low density lipoproteins from human plasma and egg yolk promotes accumulation of 1-acyl analogues of platelet-activating factor-like lipids.
    Tokumura A; Toujima M; Yoshioka Y; Fukuzawa K
    Lipids; 1996 Dec; 31(12):1251-8. PubMed ID: 8972457
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolism of platelet-activating factor (PAF; 1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine) and lyso-PAF (1-O-alkyl-2-lyso-sn-glycero-3-phosphocholine) by cultured rat Kupffer cells.
    Chao W; Siafaka-Kapadai A; Hanahan DJ; Olson MS
    Biochem J; 1989 Jul; 261(1):77-81. PubMed ID: 2775221
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Penicillium sp. F33 metabolite and its synthetic derivatives inhibit acetyl-CoA:1-O-alkyl-sn-glycero-3-phosphocholine acetyltransferase (a key enzyme in platelet-activating factor biosynthesis) and carrageenan-induced paw edema in mice.
    Yamazaki Y; Yasuda K; Matsuyama T; Ishihara T; Higa R; Sawairi T; Yamaguchi M; Egi M; Akai S; Miyase T; Ikari A; Miwa M; Sugatani J
    Biochem Pharmacol; 2013 Sep; 86(5):632-44. PubMed ID: 23817078
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-enzymatic platelet-activating factor formation by acetylated proteins.
    Thanou PG; Tsoukatos DC
    FEBS Lett; 2004 Aug; 573(1-3):11-4. PubMed ID: 15327967
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolism of platelet activating factor (1-alkyl-2-acetyl-sn-glycero-3-phosphocholine) and 1-alkyl-2-acetyl-sn-glycerol by human endothelial cells.
    Blank ML; Spector AA; Kaduce TL; Lee TC; Snyder F
    Biochim Biophys Acta; 1986 May; 876(3):373-8. PubMed ID: 3707974
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Binding of 1-0-alkyl-2-0-acetyl-sn-glycero-3-phosphocholine (thrombocyte activating factor) by plasma components. Exchange of the thrombocyte activating factor between lipoproteins and thrombocytes].
    Kulikov VI; Bergel'son LD
    Biokhimiia; 1984 Aug; 49(8):1310-5. PubMed ID: 6093897
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Copper-catalyzed oxidation mediates PAF formation in human LDL subspecies. Protective role of PAF:acetylhydrolase in dense LDL.
    Tsoukatos DC; Arborati M; Liapikos T; Clay KL; Murphy RC; Chapman MJ; Ninio E
    Arterioscler Thromb Vasc Biol; 1997 Dec; 17(12):3505-12. PubMed ID: 9437199
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biosynthesis of platelet-activating factor in glandular gastric mucosa. Evidence for the involvement of the 'de novo' pathway and modulation by fatty acids.
    Fernandez-Gallardo S; Gijon MA; Garcia MC; Cano E; Sanchez Crespo M
    Biochem J; 1988 Sep; 254(3):707-14. PubMed ID: 2848496
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ether phospholipids as inhibitors of the arachidonoyl-CoA: 1-acyl-sn-glycero-3-phosphocholine acyltransferase in macrophages.
    Herrmann DB; Ferber E; Munder PG
    Biochim Biophys Acta; 1986 Mar; 876(1):28-35. PubMed ID: 3947667
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PAF-acether-degrading acetylhydrolase in plasma LDL is inactivated by copper- and cell-mediated oxidation.
    Dentan C; Lesnik P; Chapman MJ; Ninio E
    Arterioscler Thromb; 1994 Mar; 14(3):353-60. PubMed ID: 8123638
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ether lysophospholipid-induced production of platelet-activating factor in human polymorphonuclear leukocytes.
    Sugiura T; Fukuda T; Masuzawa Y; Waku K
    Biochim Biophys Acta; 1990 Dec; 1047(3):223-32. PubMed ID: 2123719
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Platelet-activating factor stimulates prolactin release from dispersed rat anterior pituitary cells in vitro.
    Camoratto AM; Grandison L
    Endocrinology; 1989 Mar; 124(3):1502-6. PubMed ID: 2917522
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oxidation of low-density lipoproteins: effect of antioxidant content, fatty acid composition and intrinsic phospholipase activity on susceptibility to metal ion-induced oxidation.
    Croft KD; Williams P; Dimmitt S; Abu-Amsha R; Beilin LJ
    Biochim Biophys Acta; 1995 Feb; 1254(3):250-6. PubMed ID: 7857965
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.